Navigating the New Landscape: PULSE series - Your Guide to Revised Schedule M Compliance
PharmaState.Academy?
PharmaState.academy? offers easy access to training & up-skilling programs created by experts from Pharma Industry.
The pharmaceutical industry in India is on the cusp of a transformative era with the Revised Schedule M for Good Manufacturing Practices (GMP) coming into full force from January 2025. This change is set to redefine quality benchmarks, ensuring safer, higher-quality medicines for patients worldwide. However, with stricter norms and no extension in sight, compliance poses significant challenges, particularly for MSMEs, which constitute nearly 80% of the sector.
Of the 10,500 drug manufacturing units in India, only about 2,000 currently comply with WHO-GMP standards (Source). The new guidelines demand significant upgrades in infrastructure, processes, and systems, covering areas like product development reports, process validation, method validation, and post-marketing surveillance. Non-compliance risks not just operational shutdowns but also reputational damage and loss of market trust.
This means significant changes for manufacturers, especially those with annual turnovers below Rs 250 crore who have a 12-month window to adapt.
It's easy to feel overwhelmed. The new norms demand substantial investments in upgrading facilities, equipment, and processes. You're probably thinking, "Where do I even begin?"
That's where PULSE comes in. PULSE (Pharma Upgradation & Learning Series of Excellence), a comprehensive training series, has been meticulously designed to equip pharmaceutical professionals like you with the knowledge and skills needed to navigate the complex landscape of revised Schedule M compliance.
We've already covered the focused topics. Over the past 12 sessions, we've delved into critical areas like:
But the journey doesn't stop there. We're moving forward with 13 more sessions planned for 2025, diving deeper into the intricacies of the revised Schedule M guidelines. These sessions are essential for any professional seeking to ensure their organization's compliance and remain competitive in the evolving industry.
领英推荐
And here's the best part: The 13th session is completely free! This is your chance to experience PULSE firsthand and see how it can help you.
PULSE is backed by the support of key industry associations:
The future of the pharmaceutical industry lies in compliance. Join the PULSE series and equip yourself with the knowledge and skills to navigate the challenges ahead. Embrace the change, drive innovation, and ensure your organization is ready for the future.